Zecuity (transdermal sumatriptan) - Teva
NuPathe: Corporate Presentation (NuPathe) - Feb 1, 2013 - "Pain relief and nausea freedom two-hours following patch activation; Twice as many patients treated with Zecuity achieve freedom from headache pain compared to placebo; 53% of patients treated with Zecuity achieved relief from headache pain compared with 29% for placebo; 84% of patients treated with Zecuity were nausea-free compared with 63% for placebo" 
P3 data Migraine
http://ir.nupathe.com/getattachment/04471190-7a17-4a46-8140-83d7afc2ab74/NuPathe-Corporate-Presentation
 
Feb 1, 2013
 
 
2fc5d62e-881e-47da-b132-d4e1beea3db3.jpg